Concepedia

Publication | Closed Access

First-line Bevacizumab-containing Therapy for HER2-negative Metastatic Breast Cancer: Final Results from a Prospective German Study.

10

Citations

0

References

2016

Year

Andreas Schneeweiß, Frank Förster, Hans Tesch, Bahriye Aktas, Oleg Gluz, Matthias Geberth, Martin Michael Hertz-Eichenrode, W. Schönegg, Claudia Schumacher, Andreas Kutscheidt,
PubMed

Abstract

The efficacy and safety of first-line bevacizumab-paclitaxel in routine oncology practice is consistent with results from randomized trials.